NCT02785614View on ClinicalTrials.gov

PK Study of Multi-dose Trazodone Hydrochloride Prolonged-released Tablets in Healthy Chinese

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

November 30, 2017

Study Completion Date

January 4, 2018

Conditions
Depression
Interventions
DRUG

trazodone hydrochloride prolonged-release tablet

150 mg, oral administration, 1 per day

DRUG

trazodone hydrochloride tablet

50mg, oral administration 3 times per day

Trial Locations (1)

000000

Phase I Clinical Trial Centre, Chinese University of Hong Kong, Hong Kong

Sponsors
All Listed Sponsors
lead

Lee's Pharmaceutical Limited

INDUSTRY